- SaaS revenue grows 18% to $46.9
million, adjusted EBITDA1 margin of 16%
- FY 2021 new customer wins double previous year
- Record Q4 and full year 2021 incremental bookings support
23-25% SaaS revenue growth and 34-38% total revenue growth for FY
2022
OTTAWA, ON, March 1, 2022 /CNW/ - Kinaxis® (TSX: KXS) , the
authority in driving agility for fast, confident decision-making in
an unpredictable world, reported results for its fourth quarter and
year ended December 31, 2021. All amounts are in U.S. dollars.
All figures are prepared in accordance with International Financial
Reporting Standards (IFRS) unless otherwise indicated.
"We are thrilled with the accelerated momentum Kinaxis
experienced in Q4 as reflected by an all-time record level of
incremental subscription bookings brought on by another
record-breaking number of new customer wins, including globally
recognized brands. New customer wins for the year were more
than twice that of 2020 and, combined with subscription expansion
within our customer base, drove strength in both our annual
recurring revenue2 and year-end backlog. As a result, we
remain confident in our visibility into rapidly accelerating SaaS
revenue growth," said John Sicard,
President and CEO of Kinaxis. "As we exit pandemic protocols, we
continue to see supply chains at the forefront of boardroom
conversations and the news. The need for supply chain resilience
has never been more apparent and demands transformation towards
true end-to-end concurrent planning – our unique
differentiator. Kinaxis has never been more relevant nor better
positioned to serve the needs of our markets. We will continue to
invest to capture additional market share and enhance our platform
and service offerings to further distance ourselves from the
competition."
Q4 2021 Highlights
$ USD thousands,
except as otherwise indicated
|
Q4
2021
|
Q4
2020
|
Change
|
Total
Revenue
|
68,506
|
54,945
|
25%
|
SaaS
|
46,855
|
39,815
|
18%
|
Subscription term
license
|
1,442
|
1,948
|
(26%)
|
Professional
services
|
17,036
|
11,334
|
50%
|
Maintenance and
support
|
3,173
|
1,848
|
72%
|
Gross
profit
|
43,887
|
34,841
|
26%
|
|
64%
|
63%
|
|
Profit
|
(2,919)
|
(1,586)
|
84%
|
|
($0.11)/diluted
share
|
($0.06)/diluted
share
|
|
Adjusted
EBITDA(1)
|
11,277
|
6,095
|
85%
|
|
16%
|
11%
|
|
Cash from
operating activities
|
3,238
|
3,200
|
1%
|
(1)
"Adjusted EBITDA" is a non-IFRS measure and is not a recognized,
defined or a standardized measure under IFRS. This measure as well
as other non-IFRS financial measures reported by Kinaxis are
defined in the "Non-IFRS Measures" section of this news
release.
|
FY 2021 Highlights
$ USD thousands,
except as otherwise indicated
|
FY
2021
|
FY
2020
|
Change
|
Total
Revenue
|
250,726
|
224,189
|
12%
|
SaaS
|
174,463
|
148,873
|
17%
|
Subscription term
license
|
6,118
|
17,890
|
(66%)
|
Professional
services
|
57,640
|
45,899
|
26%
|
Maintenance and
support
|
12,505
|
11,527
|
8%
|
Gross
profit
|
163,971
|
154,058
|
6%
|
|
65%
|
69%
|
|
Profit
|
(1,165)
|
13,730
|
nm
|
|
($0.04/diluted
share)
|
$0.49/diluted
share
|
|
Adjusted
EBITDA(1)
|
39,851
|
53,751
|
(26%)
|
|
16%
|
24%
|
|
Cash from
operating activities
|
50,138
|
59,470
|
(16%)
|
Key Performance Indicators
The company's Annual
Recurring Revenue2 (ARR), which includes amounts related
to both SaaS and on-premise subscription contracts, rose 21% in
constant currency to $225 million at
the end of the quarter.
$USD
millions
|
2019
|
2020
|
Q1
2021
|
Q2
2021
|
Q3
2021
|
Q4
2021
|
Annual recurring
revenue2
Year-over-year
growth
|
159
21%
|
185
17%
|
191
18%
|
200
24%
|
207
23%
|
221
19%
|
Annual recurring
revenue2, constant currency
Year-over-year
growth
|
159
21%
|
183
15%
|
189
17%
|
198
23%
|
207
23%
|
225
21%
|
(2)
Annual Recurring Revenue (ARR) is the total annualized value of
recurring subscription amounts (ultimately recognized as SaaS,
Subscription Term Licenses and Maintenance & Support
revenue) of all subscription contracts at a point in time.
Annualized subscription amounts are determined solely by reference
to the underlying contracts, normalizing for the varying revenue
recognition treatments under IFRS 15 for cloud-based versus
on-premise subscription amounts. It excludes one-time fees, such as
for non-recurring professional services, and assumes that customers
will renew the contractual commitments on a periodic basis as those
commitments come up for renewal, unless such renewal is known to be
unlikely. We believe that this measure provides a more current
indication of our performance in the growth of our subscription
business than other metrics.
|
The nature of the company's long-term contracts provides
visibility into future, contracted revenue. The following table
presents revenue expected to be recognized in the future related to
performance obligations that are unsatisfied (or partially
unsatisfied) at December 31,
2021.
$USD millions
|
2022
|
2023
|
2024 and
later
|
Total
|
SaaS
|
178.9
|
132.7
|
111.9
|
423.5
|
Maintenance and
support
|
14.3
|
10.5
|
12.0
|
36.8
|
Subscription term
licenses
|
23.5
|
-
|
0
|
23.5
|
Total
|
216.7
|
143.2
|
123.9
|
483.8
|
Financial Guidance
Based on the current business outlook, Kinaxis is introducing
fiscal 2022 financial guidance, as follows:
|
FY 2022
Guidance
|
Total
revenue
|
$335-345
million
|
SaaS
|
23-25%
growth
|
Subscription term
license
|
$30-32
million
|
Adjusted
EBITDA(1) margin
|
15-18%
|
Guidance in this press release is provided to enhance visibility
into Kinaxis' expectations for financial targets for the periods
indicated. Please refer to the section regarding forward-looking
statements that forms an integral part of this release. This press
release along with the financial statements and MD&A for the
three months and year ended December 31,
2021 are available on Kinaxis' website and on SEDAR at
www.sedar.com.
Conference Call
Kinaxis will host a conference call
tomorrow, March 2, 2022, to discuss
these results. John Sicard, Chief
Executive Officer, and Blaine
Fitzgerald, Chief Financial Officer, will host the call
starting at 8:30 a.m. Eastern Time. A
question and answer session will follow management's presentation.
Investors and participants must register for the call in
advance. See registration link below. Please call the
conference telephone number fifteen minutes prior to the start
time.
DATE:
|
Wednesday, March 2,
2022
|
TIME:
|
8:30 a.m. Eastern
Time
|
CALL
REGISTRATION:
|
https://dpregister.com/sreg/10163765/f163678c39
|
WEBCAST:
|
https://bit.ly/3IUd8ke (available for three
months)
|
REPLAY:
|
(877)-344-7529
|
|
Available through
Wednesday, March 16, 2022
|
|
Reference number:
2827510
|
About Kinaxis Inc.
Everyday volatility and uncertainty
demand quick action. Kinaxis® delivers the agility to make fast,
confident decisions across integrated business planning and the
digital supply chain. People can plan better, live better and
change the world. Trusted by innovative brands, we combine human
intelligence with AI and concurrent planning to help companies plan
for any future, monitor risks and opportunities and respond at the
pace of change. Powered by an extensible, cloud-based platform,
Kinaxis delivers industry-proven applications so everyone can know
sooner, act faster and remove waste. For more Kinaxis news, follow
us on LinkedIn or Twitter.
Non-IFRS Measures
This news release contains non-IFRS
measures, specifically Adjusted EBITDA and Adjusted EBITDA margin.
We use Adjusted EBITDA to provide investors with a supplemental
measure of our operating performance and thus highlight trends in
our core business that may not otherwise be apparent when relying
solely on IFRS financial measures. We believe that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management
also uses non-IFRS measures in order to facilitate operating
performance comparisons from period to period, prepare annual
operating budgets and assess our ability to meet our capital
expenditure and working capital requirements. Adjusted EBITDA and
Adjusted EBITDA margins are not recognized, defined or standardized
measures under IFRS. Our definition of Adjusted EBITDA and Adjusted
EBITDA margin will likely differ from that used by other companies
(including our peers) and therefore comparability may be
limited. Non-IFRS measures should not be considered a
substitute for or in isolation from measures prepared in accordance
with IFRS. Investors are encouraged to review our financial
statements and disclosures in their entirety and are cautioned not
to put undue reliance on non-IFRS measures and view them in
conjunction with the most comparable IFRS financial measures.
Kinaxis has reconciled Adjusted EBITDA to the most comparable IFRS
financial measure as follows:
|
Three months
ended
December
31,
|
|
Year
ended
December
31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
(In thousands of
USD)
|
|
|
Profit
(loss)
|
$
|
(2,919)
|
|
$
|
(1,586)
|
|
$
|
(1,165)
|
|
$
|
13,730
|
Share-based
compensation
|
6,633
|
|
4,986
|
|
24,343
|
|
17,217
|
Non-recurring
item
|
716
|
|
0
|
|
(7,190)
|
|
0
|
Adjusted
profit
|
$
|
4,430
|
|
$
|
3,400
|
|
$
|
15,988
|
|
$
|
30,947
|
Income tax expense
(recovery)
|
(32)
|
|
(2,354)
|
|
2,262
|
|
7,740
|
Depreciation and
amortization
|
6,557
|
|
4,494
|
|
20,409
|
|
15,562
|
Foreign exchange
loss
|
194
|
|
364
|
|
558
|
|
196
|
Net finance expense
(income)
|
128
|
|
191
|
|
634
|
|
(694)
|
|
6,847
|
|
2,695
|
|
23,863
|
|
22,804
|
Adjusted
EBITDA
|
$
|
11,277
|
|
$
|
6,095
|
|
$
|
39,851
|
|
$
|
53,751
|
Adjusted EBITDA as a
percentage of revenue
|
16.5%
|
|
11.1%
|
|
15.9%
|
|
24.0%
|
Forward-Looking Statements
Certain statements in
this release constitute forward-looking statements within the
meaning of applicable securities laws. Forward-looking
statements include statements as to our expectations for:
- growth of annual total revenue, annual SaaS and Subscription
term licenses revenue, and our expectations for Adjusted EBITDA
margin achievement, in each case looking forward for our fiscal
year ending December 31, 2022;
and
- contracted revenue in future periods, including 2022, 2023
and 2024 and later.
This release also includes forward-looking statements as to
Kinaxis' growth opportunities and the potential benefits of, and
markets and demand for, Kinaxis' products and services. These
statements are subject to certain assumptions, risks and
uncertainties, including our view of the relative position of
Kinaxis' products and services compared to competitive offerings in
the industry.
In particular, our guidance for 2022 annual total revenue,
annual SaaS and Subscription term license revenue and annual
Adjusted EBITDA margin, is subject to certain assumptions and
associated risks including:
- our ability to win business from new customers and expand
business from existing customers;
- the timing of new customer wins and expansion decisions by
our existing customers;
- maintaining our customer retention levels, and
specifically, that customers will renew contractual commitments on
a periodic basis as those commitments come up for renewal, at rates
consistent with our historic experience; and
- with respect to Adjusted EBITDA, our ability to contain
expense levels while expanding our business.
Our guidance and commentary for achievement of contracted
revenue in future periods, including in 2022, 2023 and 2024 and
later, is based on assumptions and associated risks
including:
- our ability to satisfy material unperformed obligations
under our long-term contracts; and
- the continued financial capacity and creditworthiness of our
customers under long-term contracts.
Our guidance and commentary for annual SaaS revenue growth
beyond 2021 is based on assumptions and associated risks including
normalization of macroeconomic factors, including business and
market conditions, relative to recent conditions that have been
affected by the COVID-19 pandemic. These and other
assumptions, risks and uncertainties may cause Kinaxis' actual
results, performance, achievements and developments to differ
materially from the results, performance, achievements or
developments expressed or implied by forward-looking statements.
Material risks and uncertainties relating to our business are
described under the headings "Forward-Looking Statements" and
"Risks and Uncertainties" in our annual MD&A dated March 1, 2022, under the heading "Risk Factors"
in our Annual Information Form dated March
25, 2021 and in our other public documents filed with
Canadian securities regulatory authorities, which are available
at www.sedar.com. Forward-looking statements are
provided to help readers understand management's expectations as at
the date of this release and may not be suitable for other
purposes. Readers are cautioned not to place undue reliance on
forward-looking statements. Kinaxis assumes no obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise, except as expressly
required by law.
Kinaxis
Inc.
|
|
|
|
|
Consolidated
Statements of Financial Position
|
|
|
|
|
|
|
|
|
As at December
31
|
|
|
|
|
(Expressed in
thousands of USD)
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
Cash and cash
equivalents
|
$
|
203,220
|
$
|
182,958
|
Short-term
investments
|
|
30,168
|
|
30,180
|
Trade and other
receivables
|
|
89,247
|
|
82,883
|
Prepaid
expenses
|
|
10,282
|
|
9,264
|
Investment tax
credits recoverable
|
|
-
|
|
1,109
|
|
|
332,917
|
|
306,394
|
Non-current
assets:
|
|
|
|
|
Property and
equipment
|
|
52,093
|
|
30,746
|
Right-of-use
assets
|
|
53,578
|
|
15,722
|
Contract acquisition
costs
|
|
19,691
|
|
16,484
|
Unbilled
receivables
|
|
512
|
|
2,013
|
Other
receivables
|
|
1,096
|
|
752
|
Deferred tax
assets
|
|
6,000
|
|
2,308
|
Investment tax
credits recoverable
|
|
3,616
|
|
980
|
Intangible
assets
|
|
10,778
|
|
13,023
|
Goodwill
|
|
39,988
|
|
39,988
|
|
|
187,352
|
|
122,016
|
|
|
|
|
|
|
$
|
520,269
|
$
|
428,410
|
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Trade payables and
accrued liabilities
|
$
|
43,328
|
$
|
33,030
|
Deferred
revenue
|
|
99,239
|
|
94,275
|
Provisions
|
|
716
|
|
-
|
Lease
obligations
|
|
2,526
|
|
4,554
|
|
|
145,809
|
|
131,859
|
Non-current
liabilities:
|
|
|
|
|
Lease
obligations
|
|
53,233
|
|
12,065
|
Deferred tax
liabilities
|
|
9
|
|
2,729
|
|
|
53,242
|
|
14,794
|
Shareholders'
equity:
|
|
|
|
|
Share
capital
|
|
195,414
|
|
173,104
|
Contributed
surplus
|
|
54,739
|
|
35,846
|
Accumulated other
comprehensive loss
|
|
(597)
|
|
(20)
|
Retained
earnings
|
|
71,662
|
|
72,827
|
|
|
321,218
|
|
281,757
|
|
|
|
|
|
|
$
|
520,269
|
$
|
428,410
|
Kinaxis
Inc.
|
|
|
|
|
Consolidated
Statements of Comprehensive Income (Loss)
|
|
|
|
|
|
(Expressed in
thousands of USD, except share and per share data)
|
|
|
|
|
|
|
For the three months
ended December 31,
|
For the year ended
December 31,
|
|
2021
|
2020
|
2021
|
2020
|
|
|
|
|
|
Revenue
|
$
|
68,506
|
$
|
54,945
|
$
|
250,726
|
$
|
224,189
|
|
|
|
|
|
Cost of
revenue
|
24,619
|
20,104
|
86,755
|
70,131
|
|
|
|
|
|
Gross
profit
|
43,887
|
34,841
|
163,971
|
154,058
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
Selling and
marketing
|
16,960
|
15,521
|
59,078
|
52,630
|
Research and
development
|
16,465
|
13,822
|
57,424
|
47,420
|
General and
administrative
|
13,183
|
8,983
|
45,550
|
33,232
|
|
46,608
|
38,326
|
162,052
|
133,282
|
|
|
|
|
|
|
(2,721)
|
(3,485)
|
1,919
|
20,776
|
|
|
|
|
|
Other income
(expense):
|
|
|
|
|
Foreign exchange
loss
|
(194)
|
(364)
|
(558)
|
(196)
|
Net finance and other
income (expense)
|
(36)
|
(91)
|
(264)
|
890
|
|
(230)
|
(455)
|
(822)
|
694
|
|
|
|
|
|
Profit (loss) before
income taxes
|
(2,951)
|
(3,940)
|
1,097
|
21,470
|
|
|
|
|
|
Income tax expense
(recovery)
|
(32)
|
(2,354)
|
2,262
|
7,740
|
|
|
|
|
|
Profit
(loss)
|
(2,919)
|
(1,586)
|
(1,165)
|
13,730
|
|
|
|
|
|
Other comprehensive
income (loss):
|
|
|
|
|
|
|
|
|
|
Items that are or may
be reclassified subsequently to profit or loss:
|
|
|
|
|
Foreign currency
translation differences - foreign operations
|
(124)
|
237
|
(577)
|
328
|
|
|
|
|
|
Total comprehensive
income (loss)
|
$
|
(3,043)
|
$
|
(1,349)
|
$
|
(1,742)
|
$
|
14,058
|
|
|
|
|
|
Basic earnings (loss)
per share
|
$
|
(0.11)
|
$
|
(0.06)
|
$
|
(0.04)
|
$
|
0.51
|
|
|
|
|
|
Weighted average
number of basic common shares
|
27,372,618
|
26,993,691
|
27,248,193
|
26,716,027
|
|
|
|
|
|
Diluted earnings
(loss) per share
|
$
|
(0.11)
|
$
|
(0.06)
|
$
|
(0.04)
|
$
|
0.49
|
|
|
|
|
|
Weighted average
number of diluted common shares
|
27,372,618
|
26,993,691
|
27,248,193
|
28,138,911
|
Kinaxis
Inc.
|
|
|
|
|
|
Consolidated
Statements of Changes in Shareholders' Equity
|
|
|
|
|
|
|
For the years ended
December 31
|
|
(Expressed in
thousands of USD)
|
|
|
|
|
|
|
|
|
Share
capital
|
Contributed
surplus
|
Accumulated other
comprehensive loss
|
Retained
earnings
|
Total
equity
|
|
|
|
|
|
|
Balance, December 31,
2019
|
$
|
140,961
|
$
|
30,392
|
$
|
(348)
|
$
|
59,097
|
$
|
230,102
|
|
|
|
|
|
|
Profit
|
-
|
-
|
-
|
13,730
|
13,730
|
Other comprehensive
income
|
-
|
-
|
328
|
-
|
328
|
Total comprehensive
income
|
-
|
-
|
328
|
13,730
|
14,058
|
|
|
|
|
|
|
Share options
exercised
|
27,187
|
(6,807)
|
-
|
-
|
20,380
|
Restricted share
units vested
|
4,956
|
(4,956)
|
-
|
-
|
-
|
Share-based
payments
|
-
|
17,217
|
-
|
-
|
17,217
|
Total shareholder
transactions
|
32,143
|
5,454
|
-
|
-
|
37,597
|
|
|
|
|
|
|
Balance, December 31,
2020
|
$
|
173,104
|
$
|
35,846
|
$
|
(20)
|
$
|
72,827
|
$
|
281,757
|
|
|
|
|
|
|
Loss
|
-
|
-
|
-
|
(1,165)
|
(1,165)
|
Other comprehensive
loss
|
-
|
-
|
(577)
|
-
|
(577)
|
Total comprehensive
loss
|
-
|
-
|
(577)
|
(1,165)
|
(1,742)
|
|
|
|
|
|
|
Share options
exercised
|
14,221
|
(3,459)
|
-
|
-
|
10,762
|
Restricted share
units vested
|
8,089
|
(8,089)
|
-
|
-
|
-
|
Share-based
payments
|
-
|
30,441
|
-
|
-
|
30,441
|
Total shareholder
transactions
|
22,310
|
18,893
|
-
|
-
|
41,203
|
|
|
|
|
|
|
Balance, December 31,
2021
|
$
|
195,414
|
$
|
54,739
|
$
|
(597)
|
$
|
71,662
|
$
|
321,218
|
Kinaxis
Inc.
|
|
|
|
|
Consolidated
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
(Expressed in
thousands of USD)
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended December 31,
|
For the year ended
December 31,
|
|
2021
|
2020
|
2021
|
2020
|
|
|
|
|
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
|
|
|
Profit
(loss)
|
$
|
(2,919)
|
$
|
(1,586)
|
$
|
(1,165)
|
$
|
13,730
|
Items not affecting
cash:
|
|
|
|
Depreciation of
property and equipment and right-of-use assets
|
5,995
|
3,932
|
18,164
|
14,335
|
Amortization of
intangible assets
|
562
|
562
|
2,245
|
1,227
|
Share-based
payments
|
6,633
|
4,986
|
24,343
|
17,217
|
Net finance expense
(income)
|
406
|
91
|
634
|
(890)
|
Income tax expense
(recovery)
|
(32)
|
(2,354)
|
2,262
|
7,740
|
Investment tax credits
recoverable
|
(1,356)
|
(2,089)
|
(1,527)
|
(2,089)
|
Change in operating
assets and liabilities
|
(5,846)
|
18
|
5,523
|
10,492
|
Interest
received
|
37
|
103
|
428
|
1,761
|
Interest
paid
|
(442)
|
(187)
|
(1,050)
|
(674)
|
Income taxes received
(paid)
|
200
|
(276)
|
281
|
(3,379)
|
|
3,238
|
3,200
|
50,138
|
59,470
|
|
|
|
|
|
Cash flows used
investing activities:
|
|
|
|
|
|
|
|
|
|
Acquisition of
business, net of cash acquired
|
-
|
(24)
|
(800)
|
(61,767)
|
Purchase of property
and equipment
|
(11,464)
|
(2,102)
|
(33,833)
|
(14,439)
|
Purchase of short-term
investments
|
(26,434)
|
(15,164)
|
(71,599)
|
(110,616)
|
Redemption of
short-term investments
|
26,434
|
15,154
|
71,599
|
110,558
|
|
(11,464)
|
(2,136)
|
(34,633)
|
(76,264)
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
|
Payment of lease
obligations
|
(1,411)
|
(1,103)
|
(4,911)
|
(3,742)
|
Common shares issued
on exercise of stock options
|
2,577
|
2,484
|
10,762
|
20,380
|
|
1,166
|
1,381
|
5,851
|
16,638
|
|
|
|
|
|
Increase (decrease)
in cash and cash equivalents
|
(7,060)
|
2,445
|
21,356
|
(156)
|
|
|
|
|
|
Cash and cash
equivalents, beginning of period
|
210,382
|
179,856
|
182,958
|
182,284
|
|
|
|
|
|
Effects of exchange
rates on cash and cash equivalents
|
(102)
|
657
|
(1,094)
|
830
|
|
|
|
|
|
Cash and cash
equivalents, end of period
|
$
|
203,220
|
$
|
182,958
|
$
|
203,220
|
$
|
182,958
|
SOURCE Kinaxis Inc.